Back to results
US 9,192,585 B2Granted
Inhibitors of cognitive decline
AssigneeCognition Therapeutics, Inc.
InventorsGilbert M. Rishton, Susan Catalano
Life of this patent
Estimating the term…
Abstract
Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods of treating, inhibiting, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.
Claims1
A compound-selected from:
- 2-methyl-6-(4-methylcyclohexa-1,5-dienyl)hept-2-en-4-ol;
- N-isobutyl-2-methyl-6-(4-methylcyclohexa-1,5-dienyl)hept-2-en-4-amine;
- (6S)-2-methyl-6-(4-methylcyclohexa-1,5-dienyl)hept-2-en-4-ol;
- (6S)—N-isobutyl-2-methyl-6-(4-methylcyclohexa-1,5-dienyl)hept-2-en-4-amine;
- (6R)-2-methyl-6-(4-methylcyclohexa-1,5-dienyl)hept-2-en-4-ol;
- and
- (6R)—N-isobutyl-2-methyl-6-(4-methylcyclohexa-1,5-dienyl)hept-2-en-4-amine;
- or pharmaceutically acceptable salt thereof.
5 more elements
Dependencies are inferred from the claim text.